МИГРЕНЬ И ЕГО РАНЯЯ ДИАГНОСТИКА И ЛЕЧЕНИЕ
Keywords:
мигрень, терапия мигрени, диагностика, лечения.Abstract
Статья посвящена современным подходам диагностики и лечения приступов мигрени, актуальным для практикующего врача. Рассматриваются основные принципы диагностики острых мигренозных приступов, лечение включающие выбор препаратов в зависимости с учетём индивидуальных особенностей пациента. Для диагностики заболевания врачу нужно понять характер, интенсивность и частоту приступов головной боли, выявить провоцирующие факторы и оценить результаты лечения. Лечение мигрени направлено на уменьшение частоты и интенсивности приступов, на снижение количества принимаемых обезболивающих препаратов. Оно включает три основных подхода: поведенческая терапия, терапия для купирования приступов и профилактическая терапия.
References
1. World Health Organization. Atlas of headache disorders and resources in the world 2011. A collaborative project of World Health Organization and Lifting the Burden. Geneva, Switzerland: WHO; 2011. 69 p.
2. GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet 2020 Oct;396(10258):1204-22.
3. Steiner TJ, Stovner LJ. Global epidemiology of migraine and its implications for public health and health policy. Nature Reviews. Neurology 2023 Feb;19(2):109-17
4. Riederer F, Beiersdorf J, Scutelnic A, Schankin CJ. Migraine Aura—Catch Me If You Can with EEG and MRI—A Narrative Review. Diagnostics. 2023 Sep 2;13(17):2844.
5. Sanchez-Sanchez PA, García-González JR, Rúa Ascar JM. Automatic migraine classification using artificial neural networks. F1000Res. 2020 Jun 16;9:618. doi: 10.12688/f1000research.23181.2. PMID: 34745568; PMCID: PMC8564744.
6. Hauge A.W., Kirchmann M., Olesen J. Characterization of consistent triggers of migraine with aura. Cephalalgia 2011;31(4):416–38
7. The International Classification of Headache Disorders, 3rd edition (ICHD-3). Cephalalgia. 2018;38(1):1-211. doi: 10.1177/0333102417738202
8. Lipton RB, Serrano D, Buse DC, et al. Improving the detection of chronic migraine: Development and validation of Identify Chronic Migraine (ID-CM). Cephalalgia. 2016;36(3):203-15. doi: 10.1177/0333102415583982
9. Артеменко АР, Куренков АЛ, Беломестова КВ. Классификация, диагностика и лечение хронической мигрени: обзор новых данных. Журнал неврологии и психиатрии им. С.С. Корсакова.
10. Silberstein S.D. Migraine. Lancet 2004;363:381–91.
11. Амелин А.В., Игнатов Ю.Д., Скоромец А.А., Соколов А.Ю. Мигрень. Патогенез, клиника, фармакотерапия: руководство для врачей. М.: МЕДпресс-информ, 2011;265 с
12. Mett A, Tfelt-Hansen P. Acute migraine therapy: recent evidence from randomized comparative trials. Curr Opin Neurol. 2008;21(3):331-7. doi: 10.1097/WCO.0b013e3282fee843
13. Orr SL, Aube M, Becker WJ, et al. Canadian Headache Society systematic review and recommendations on the treatment of migraine pain in emergency settings. Cephalalgia. 2015;35:271. doi: 10.1177/0333102414535997
14. Kirthi V, Derry S, Moore R. Aspirin with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev. 2013;4:CD008041. doi: 10.1002/14651858.CD008041.pub3
15. Lampl C, Voelker M, Diener HC. Efficacy and safety of 1,000 mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms. J Neurol. 2007;254(6):705-12. doi: 10.1007/s00415-007-0547-2
16. Suthisisang C, Poolsup N, Kittikulsuth W, et al. Efficacy of low-dose ibuprofen in acute migraine treatment: systematic review and meta-analysis. Ann Pharmacother. 2007;41(11):1782-91. doi: 10.1345/aph.1K121
17. Rabbie R, Derry S, Moore RA. Ibuprofen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev. 2013;4:CD008039. doi: 10.1002/14651858.CD008039.pub3
18. Suthisisang CC, Poolsup N, Suksomboon N, et al. Meta-analysis of the efficacy and safety of naproxen sodium in the acute treatment of migraine. Headache. 2010;50(5):808-18. doi: 10.1111/j.1526-4610.2010.01635.x
19. Law S, Derry S, Moore RA. Naproxen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev. 2013;10:CD009455. doi: 10.1002/14651858.CD009455.pub2
20. Derry S, Rabbie R, Moore RA. Diclofenac with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev. 2013;4:CD008783. doi: 10.1002/14651858.CD008039.pub3
21. Derry S, Moore RA. Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev. 2013;4:CD008040. doi: 10.1002/14651858.CD008040.pub3
22. Diener HC, Montagna P, Gacs G, et al. Efficacy and tolerability of diclofenac potassium sachets in migraine: A randomized, doubleblind, cross-over study in comparison with diclofenac potassium tablets and placebo. Cephalalgia. 2006;26:537-47. doi: 10.1111/j.1468-2982.2005.01064.x
23. Colman I, Brown MD, Innes GD, et al. Parenteral metoclopramide for acute migraine: meta-analysis of randomised controlled trials. BMJ. 2004;329(7479):1369-73. doi: 10.1136/bmj.38281.595718.7C 12 Неврология, нейропсихиатрия, психосоматика. 2020;12(4):4–14 КЛИНИЧЕСКИЕ РЕКОМЕНДАЦИИ
24. Shrestha M, Singh R, Moreden J, Hayes JE. Ketorolac vs chlorpromazine in the treatment of acute migraine without aura. A prospective, randomized, double-blind trial. Arch Intern Med. 1996;156:1725-8. doi: 10.1001/archinte.1996.00440140163017
25. Katsarava Z, Buse DC, Manack AN, Lipton RB. Defining the differences between episodic migraine and chronic migraine. Curr Pain Headache Rep. 2012;16(1):86-92. doi: 10.1007/s11916-011-0233-z
26. Осипова ВВ. Психологические аспекты боли. Неврология, нейропсихиатрия, психосоматика. 2010;2(1):4-8. doi: 10.14412/2074-2711-2010-62 [Osipova VV. Pain: psychological aspects. Nevrologiya, neyropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2010;2(1):4-9. doi: 10.14412/2074-2711-2010- 62 (In Russ.)].
27. Raggi A, Grignani E, Leonardi M, et al. Behavioral Approaches for Primary Headaches: Recent Advances. Headache. 2018;58(6):913- 25. doi: 10.1111/head.13337
28. Головачева ВА, Парфенов ВА. Когнитивно-поведенческая терапия в лечении пациентов с мигренью. Неврологический журнал. 2015;3(20):37-43. [Golovacheva VA, Parfenov VA. Cognitive Behavioral Therapy in the Treatment of Migraine Patients. Nevrologicheskiy zhurnal. 2015;3(20):37-43 (In Russ.)].
29. Sharpe L, Dudeney J, Williams ACDC, et al. Psychological therapies for the prevention of migraine in adults. Cochrane Database Syst Rev. 2019;7:CD012295. doi: 10.1002/14651858.CD012295.pub2
30. Evers S, Afra J, Frese A, et al; European Federation of Neurological Societies. EFNS guideline on the drug treatment of migraine – revised report of an EFNS task force. Eur J Neurol. 2009;16:968-81. doi: 10.1111/j.1468-1331.2009.02748.x
31. Harris P, Loveman E, Clegg A, et al. Systematic review of cognitive behavioural therapy for the management of headaches and migraines in adults. Br J Pain. 2015;9(4):213- 24. doi: 10.1177/2049463715578291
32. Luedtke K, Allers A, Schulte LH, May A. Efficacy of interventions used by physiotherapists for patients with headache and migraine. Systematic review and meta-analysis. Cephalalgia. 2016;36(5):474-92. doi: 10.1177/0333102415597889
33. 104. Lee HJ, Lee JH, Cho EY, et al. Efficacy of psychological treatment for headache disorder: a systematic review and meta-analysis. J Headache Pain. 2019;20(1):17. doi: 10.1186/s10194-019-0965-4
34. Anheyer D, Leach MJ, Klose P, et al. Mindfulness-based stress reduction for treating chronic headache: A systematic review and meta-analysis. Cephalalgia. 2019;39(4):544- 55. doi: 10.1177/0333102418781795
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.



